SPSK2 PUM, Klinika Kardiologii
Szczecin, Poland
Medical center in Szczecin
al. Powstańców Wielkopolskich 72, 71-899 Szczecin
About SPSK2 PUM, Klinika Kardiologii
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
2
Clinical Trials at SPSK2 PUM, Klinika Kardiologii
During the past decade, SPSK2 PUM, Klinika Kardiologii conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
2019-07-29
2024-09-24
Active, not recruiting
187
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
2022-05-04
2027-01-31
Recruiting
252
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SPSK2 PUM, Klinika Kardiologii
According to Clinical.Site data, the most researched conditions in "SPSK2 PUM, Klinika Kardiologii" are
"Hypertension, Pulmonary" (1 trials) and "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials). Many other conditions were trialed in "SPSK2 PUM, Klinika Kardiologii" in a lesser frequency.
Clinical Trials Intervention Types at SPSK2 PUM, Klinika Kardiologii
Most popular intervention types in "SPSK2 PUM, Klinika Kardiologii" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "FDC macitentan/tadalafil" (1 trials), "FDC of Macitentan and Tadalafil" (1 trials), "Macitentan" (1 trials), "Macitentan 10 mg" (1 trials) and "Placebo FDC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SPSK2 PUM, Klinika Kardiologii
The vast majority of trials in "SPSK2 PUM, Klinika Kardiologii" are
2 trials for "All" genders.
Clinical Trials Status at SPSK2 PUM, Klinika Kardiologii
Currently, there are NaN active trials in "SPSK2 PUM, Klinika Kardiologii".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in SPSK2 PUM, Klinika Kardiologii,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SPSK2 PUM, Klinika Kardiologii, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".